Behzad Aghazadeh's Insider Trades & SAST Disclosures
Behzad Aghazadeh's most recent trade in Whitehawk Therapeutics Inc. was a trade of 8,333,000 Pre-funded Warrant (right to buy) done . Disclosure was reported to the exchange on Feb. 28, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Behzad Aghazadeh.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Whitehawk Therapeutics Inc. | Behzad Aghazadeh | Director, Ten Percent Owner, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 8,333,000 | 8,333,000 | - | - | Pre-funded Warrant (right to buy) | |
| Whitehawk Therapeutics Inc. | Behzad Aghazadeh | Director, Ten Percent Owner, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,832 | 45,832 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc. | Behzad Aghazadeh | Director, Ten Percent Owner, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 28,255 | 28,255 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc. | Behzad Aghazadeh | Director, Ten Percent Owner, See Remarks | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 22 Sep 2022 | 1,260,000 | 3,471,752 | - | 12.5 | 15,750,000 | Common Stock, $0.0001 par value per share ("Common Stock") |
| Whitehawk Therapeutics Inc. | Behzad Aghazadeh | Director, Ten Percent Owner, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,573 | 18,573 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc. | Behzad Aghazadeh | Director, Ten Percent Owner, See Remarks | Grant, award, or other acquisition of securities at price $ 13.08 per share. | 26 Aug 2021 | 1,911,752 | 2,211,752 | - | 13.1 | 24,999,981 | Common Stock, $0.0001 par value per share ("Common Stock") |
| Whitehawk Therapeutics Inc. | Behzad Aghazadeh | Director, Ten Percent Owner, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 17,549 | 17,549 | - | - | Stock option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges